The comparison of the efficacy of two therapeutic regimens in the treatment of gastroesophageal reflux disease in term neonates.
Not Applicable
Recruiting
- Conditions
- Gastroesophageal Reflux.Gastro-oesophageal reflux disease
- Registration Number
- IRCT20160827029535N5
- Lead Sponsor
- Bahrami hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Healthy term neonates aged 1–30days with GERD .
Exclusion Criteria
Healthy term neonates aged 1–30days with GERD not responding to conservative therapies including antireflux positioning, milk thickening, hypoallergic regimens and monotherapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The comparison of ranitidine with esomeprazole in neonatal GERD. Timepoint: One week and one month after using each drug. Method of measurement: using (I-GERDQ-R) and related scoring.
- Secondary Outcome Measures
Name Time Method The side effects of each drug. Timepoint: After one week and one month of administering. Method of measurement: Clinical manifestations.